|
|
Volumn 115, Issue 3, 2001, Pages 713-714
|
|
Bone marrow aplasia after pipobroman: An immune-mediated mechanism? [4]
a
|
|
Author keywords
Aplasia; Chronic myeloproliferative disorders; Essential thrombocythaemia; Pipobroman
|
|
Indexed keywords
CHLORAMPHENICOL;
CYCLOSPORIN;
HYDROXYUREA;
IMMUNOSUPPRESSIVE AGENT;
PIPOBROMAN;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
APLASTIC ANEMIA;
BLOOD CELL COUNT;
BONE MARROW APLASIA;
BONE MARROW BIOPSY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
CONVALESCENCE;
DISEASE COURSE;
DISEASE DURATION;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG INDUCED DISEASE;
ERYTHROCYTE TRANSFUSION;
FEMALE;
HEMATOPOIESIS;
HEMOGLOBIN DETERMINATION;
HUMAN;
HUMAN CELL;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
MYELOFIBROSIS;
PANCYTOPENIA;
PRIORITY JOURNAL;
REMISSION;
THROMBOCYTE TRANSFUSION;
THROMBOCYTHEMIA;
TREATMENT OUTCOME;
AGED;
AGED, 80 AND OVER;
ANEMIA, APLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CHRONIC DISEASE;
CYCLOSPORINE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MIDDLE AGED;
PIPOBROMAN;
THROMBOCYTHEMIA, HEMORRHAGIC;
|
|
EID: 0035676758
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2001.03138-4.x Document Type: Letter |
|
Times cited : (2)
|
|
References (7)
|
